1. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773–1780PMID : 12050336.
2. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315–1323PMID : 14523139.
3. Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003;108:788–794PMID : 12900339.
4. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221–231PMID : 14724301.
5. Degertekin M, Regar E, Tanabe K, et al. Evaluation of coronary remodeling after sirolimus-eluting stent implantation by serial three-dimensional intravascular ultrasound. Am J Cardiol 2003;91:1046–1050PMID : 12714144.
6. Kim SH, Hong MK. Current status of drug-eluting stents. The Korean J Med 2008;75:370–382.
7. Morino Y, Kaneda H, Fox T, et al. Delivered dose and vascular response after beta-radiation for in-stent restenosis: retrospective dosimetry and volumetric intravascular ultrasound analysis. Circulation 2002;106:2334–2339PMID : 12403663.
8. Honda Y, Grube E, de La Fuente LM, Yock PG, Stertzer SH, Fitzgerald PJ. Novel drug-delivery stent: intravascular ultrasound observations from the first human experience with the QP2-eluting polymer stent system. Circulation 2001;104:380–383PMID : 11468196.
9. Kobayashi Y, Honda Y, Christie GL, et al. Long-term vessel response to a self-expanding coronary stent: a serial volumetric intravascular ultrasound analysis from the ASSURE trial. J Am Coll Cardiol 2001;37:1329–1334PMID : 11300443.
10. Ako J, Morino Y, Honda Y, et al. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 2005;46:1002–1005PMID : 16168282.
11. Dawkins KD, Grube E, Guagliumi G, et al. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation 2005;112:3306–3313PMID : 16286586.
12. Chen JL, Gao RL, Yang YJ, et al. Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteries. Chin Med J 2006;119:21–25PMID : 16454977.
13. Kumar S, Suresh V, Prendergast BD, et al. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents. Catheter Cardiovasc Interv 2006;68:663–668PMID : 17034063.
14. Grube E, Dawkins KD, Guagliumi G, et al. TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions. Eur Heart J 2007;28:2578–2582PMID : 17938126.
15. Urban P, Gershlick AH, Guagliumi G, et al. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation 2006;113:1434–1441PMID : 16534015.
16. Galløe AM, Thuesen L, Kelbaek H, et al. Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial. JAMA 2008;299:409–416PMID : 18230778.
17. Roy P, Torguson R, Okabe T, et al. Comparison between sirolimus- and paclitaxel-eluting stents in complex patient and lesions subsets. Catheter Cardiovasc Interv 2007;70:167–172PMID : 17503503.
18. Morice MC, Colombo A, Meier B, et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions. The REALITY trial: a randomized controlled trial. JAMA 2006;295:895–904PMID : 16493102.
19. Windecker S, Remondino A, Eberli FR, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 2005;353:653–662PMID : 16105989.
20. Dibra A, Kastrati A, Mehilli J, et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005;353:663–670PMID : 16105990.
21. Cervinka P, Costa MA, Angiolillo DJ, et al. Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: an intravascular ultrasound study. Catheter Cardiovasc Interv 2006;67:846–851PMID : 16683273.
22. Petronio AS, De Carlo M, Branchitta G, et al. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study. J Am Coll Cardiol 2007;49:539–546PMID : 17276176.
23. Colombo A, Orlic D, Stankovic G, et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 2003;107:2178–2180PMID : 12719283.
24. Iakovou I, Schmidt T, Ge L, et al. Angiographic patterns of restenosis after paclitaxel-eluting stent implantation. J Am Coll Cardiol 2005;45:805–806PMID : 15734629.
25. Kimura M, Mintz GS, Carlier S, et al. Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound. Am J Cardiol 2006;98:436–442PMID : 16893693.
26. Takeuchi H, Morino Y, Fujibayashi D, et al. Frequency and characteristics of incomplete stent apposition during and after sirolimus-eluting stent implantation. J Cardiol 2007;50:111–118PMID : 17802694.
27. Hong MK, Mintz GS, Lee CW, et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 2006;113:414–419PMID : 16432073.